The aging of France all but guarantees a continuous rise in diseases that target the elderly. And perhaps the most devastating is Alzheimer’s – a disease that robs people of their memories, their independence, and their right to age with dignity.  The big question is: Is France taking the actions needed to prepare for the looming Alzheimer’s pandemic? 

It is the modern epidemic claiming a new victim every three seconds. Fifty million people in the world have the disease now, and that number is forecast to double over the next 20 years, and every 20 years thereafter.

Dementia Innovation Readiness Index Issues Call-to-Action for Argentina, Brazil, China, India, and Saudi Arabia to Prioritize National Plans, Earlier Detection and Diagnosis, Quality Care, and Awareness Campaigns (Chicago – July 27, 2018) – Today, the Global Coalition on Aging (GCOA) and Alzheimer’s Disease International (ADI) will present findings from the 2018 Dementia Innovation Readiness Index…

New guidance provides clarity on endpoints, will help spur pharmaceutical innovation for Alzheimer’s treatments NEW YORK, NY (17 May 2018) – The Global Coalition on Aging (GCOA) today submitted comments to the U.S. Food & Drug Administration (FDA) supporting the administration’s new regulatory guidance document on early Alzheimer’s disease and calling for similar updates for related dementias….

KYOTO (April 26, 2017) – Today, the Global Coalition on Aging (GCOA) and Alzheimer’s Disease International (ADI) launched the Dementia Innovation Readiness Index, a first-ever comprehensive evaluation of innovation in dementia treatment, prevention, and care across G7 countries. “Since the last new treatment for Alzheimer’s disease entered the market more than a decade ago, the…